Home › Funds › DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt › CVS

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt position in CVS

CVS HEALTH CORP · Consumer Staples

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt reported holding 4,942,871 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$511.3M, representing 0.61% of its reported portfolio and ranking #49 among its reported holdings. DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.94M sh
Reported value held$511.34M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt's CVS position evolved

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt first disclosed a stake in CVS in Q3 2023 at 300,000 shares (US$21.0M). The position peaked in Q4 2025 at 9,371,595 shares, worth US$743.7M. Across 12 filings, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,942,871 shares valued at US$511.3M — an increase of 127,049 shares quarter over quarter.. Notable position changes include a 246% increase in Q4 2023 (shares rose 2% over the following quarter), a 102% increase in Q3 2025 (shares rose 6% over the following quarter), a 822% increase in Q4 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 300.00K $20.99M New
Q4 2023 1.04M $81.92M Add
Q1 2024 485.95K $38.76M Reduce
Q2 2024 557.08K $32.90M Add
Q3 2024 532.58K $33.49M Reduce
Q4 2024 391.09K $17.56M Reduce
Q1 2025 393.68K $26.67M Add
Q2 2025 503.24K $34.71M Add
Q3 2025 1.02M $76.62M Add
Q4 2025 9.37M $743.73M Add
Q1 2026 4.82M $345.87M Reduce
Q2 2026 4.94M $511.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt held CVS?

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt's current position in CVS?

As of Q2 2026, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt holds 4.94M shares of CVS (CVS HEALTH CORP), valued at $511.34M, representing 0.61% of its reported portfolio and ranking #49.

Has DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt been buying or selling CVS?

In the latest 13F filing (Q2 2026), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt increased its position in CVS. The position peaked in Q4 2025 at 9.37M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.